Liver/Biliary Disorders News

Global burden of hepatitis B virus is estimated to be 257.5 million individuals, according to recent data in Lancet Gastroenterology & Hepatology, which, although lower than current WHO estimates, falls short of 2030 elimination targets.

Adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease had a more than 5% reduction in liver fat at 6 months with growth hormone therapy, according to findings from a randomized controlled trial.

Maternal hepatitis B virus serostatus was not associated with pregnancy outcomes in infertile women in China who underwent freeze-thaw embryo transfer, according to data in JAMA Network Open.

Topline findings from the phase 2a DUET trial showed that Tern Pharmaceuticals’ oral thyroid hormone receptor-beta agonist achieved significant reductions in liver fat content among patients with nonalcoholic steatohepatitis.

Bolstering the introduction of hepatitis B birth dose vaccines and verifying progress in eliminating mother-to-child transmission are among strategies critical to achieving hepatitis B virus control in Africa, WHO and CDC researchers wrote.

Postmenopausal women who consumed at least one sugar-sweetened soft drink per day had significantly higher incidence of liver cancer and chronic liver disease mortality, compared with those who drank no more than three beverages per month.

The AGA applauded the reintroduction of the Treat and Reduce Obesity Act into the 118th Congress as this bill would expand Medicare coverage for screening and treatment of obesity by health care providers specializing in obesity care.

Women with intrahepatic cholestasis of pregnancy delivered earlier and had a lower percentage of stillbirths compared with women without the liver disorder, researchers reported in the American Journal of Obstetrics & Gynecology.

Higher intake of total and dairy protein and lower animal protein consumption correlated with a reduced risk for mortality among patients with cirrhosis, according to data published in BMC Gastroenterology.

A familial risk score comprised of age, obesity, type 2 diabetes and family history of nonalcoholic fatty liver disease accurately identified advanced fibrosis among first-degree relatives, according to researchers.